Straits Times Index
3,303.59 -0.07 (-0.00%) Nikkei
38,327.86 +148.40 (+0.39%) Hang Seng
19,101.83 -13.23 (-0.07%) FTSE 100
8,414.99 -18.77 (-0.22%) Bitcoin USD
61,946.34 +854.84 (+1.40%) CMC Crypto 200
1,289.52 -1.88 (-0.15%)
INO Jan 2025 1.500 put
| Previous close | 0.8000 |
| Open | 0.8000 |
| Bid | 0.8500 |
| Ask | 0.9500 |
| Strike | 1.50 |
| Expiry date | 2025-01-17 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
PR NewswireINOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2024 and provided an update on recent company developments.
- PR Newswire
INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the "Inducement Plan").
- PR Newswire
INOVIO to Participate in Upcoming Investor Conferences in May
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of May:
